Synonyms: 1-[(5R)-4,5-Dihydro-5-phenyl-1H-pyrazol-1-yl]-2,2-dimethyl-1-propanone; 2,2-Dimethyl-1-(5(R)-phenyl-4,5-dihydro-pyrazol-1-yl)-propan-1-one; GSK 962; GSK 963 inactive control; GSK 963 negative control; GSK' 962A; GSK'962A; GSK'963 inactive control; GSK'963 negative control; GSK-962; GSK-962A; GSK962; GSK962A
Molecular Formula: C14H18N2O
Molecular Weight: 230.31
Linear Structural Formula: C14H18N2O
Purity: >=98% (HPLC)
Storage: 2-8C
Biochem Physiol Actions: GSK'962 (GSK'962A) corresponds to the inactive (R)-enantiomer of the highly potent and selective RIPK1 (RIP1) inhibitor GSK'963 (GSK'963A). GSK'962 serves as an ideal GSK'963 negative control compound for probing RIPK1-mediated responses both in vitro and in vivo.